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Recent evidence indicates that immune cells contribute to the formation of tumor
metastases by regulating the pre-metastatic niche. Whether tumor-derived factors
involved in primary tumor formation play a role in metastasis formation is poorly
characterized. Oxysterols act as endogenous regulators of lipid metabolism through the
interaction with the nuclear Liver X Receptors-(LXR)α and LXRβ. In the context of tumor
development, they establish a pro-tumor environment by dampening antitumor immune
responses, and by recruiting pro-angiogenic and immunosuppressive neutrophils.
However, the ability of LXR/oxysterol axis to promote tumor invasion and metastasis
by exploiting immune cells, is still up to debate. In this study we provide evidence
that oxysterols participate in the primary growth of orthotopically implanted 4T1 breast
tumors by establishing a tumor-promoting microenvironment. Furthermore, we show
that oxysterols are involved in the metastatic spread of 4T1 breast tumors, since their
enzymatic inactivation mediated by the sulfotransferase 2B1b, reduces the number of
metastatic cells in the lungs of tumor-bearing mice. Finally, we provide evidence that
oxysterols support the metastatic cascade by modifying the lung metastatic niche,
particularly allowing the recruitment of tumor-promoting neutrophils. These results
identify a possible new metastatic pathway to target in order to prevent metastasis
formation in breast cancer patients.
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INTRODUCTION
The role exerted by inflammation in promoting tumor cell formation (neoplastic transformation)
as well as the mechanisms of immune escape favoring tumor growth have recently been considered
as pillars of cancer hallmarks (1). Emphasis has recently been given to metabolic pathways altered
in cancer cells, which may condition tumor-infiltrating immune cells. On the other hand, defined
metabolic pathways specific for immune cell subsets have been identified. Metabolites produced by
cancer cells may hamper the antitumor immune response by affecting distinct tumor-infiltrating
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immune cells (2). Among these factors cholesterol metabolites,
namely oxysterols, help tumor progression by promoting
immunosuppressive networks or angiogenesis. Oxysterols are
formed through two different pathways, enzymatic reactions
or non-enzymatic reactions initiated by non-radical ROS or
by inorganic free-radical species (3, 4). Some oxysterols are
generated exclusively by either pathways, while others can be
produced by both (5, 6). Oxysterols were identified as ligands of
the nuclear Liver X Receptors (LXRs) (7).
LXRα and LXRβ, respectively encoded by NR1H3 andNR1H2
gene, belong to a superfamily of nuclear receptors activated upon
ligand binding (8). LXRs function as heterodimers with retinoid
X receptors (RXR) and bind to a specific DNA sequence, called
LXRE. The activation of LXRs increases the rate of cholesterol
efflux from cells via ABCG1 and ABCA1 cholesterol transporters,
and lipogenesis mainly through the induction of the sterol
regulatory element-binding protein 1c (SREBP-1c) (8). Besides
lipid homeostasis, these receptors control carbohydrate and
energy metabolism (9). LXRs/LXR ligands/oxysterols integrate
cholesterol metabolism and inflammation (10). Indeed, many
inflammatory processes and immune cells respond to the
modification of this axis through the activation of specific
anti-inflammatory programs (11). LXRs/LXR ligands/oxysterols
participate in tumor formation directly by promoting primary
tumor growth (12) or indirectly by modulating the antitumor
immune response (13). Inmousemodels of melanoma and breast
tumors, the activation of LXR signaling in tumor cells and/or
in stromal cells was shown to promote invasion and metastasis
(14, 15). Specifically, in breast tumors the activation of LXRs
was shown to induce epithelial-mesenchymal transition (EMT),
ultimately contributing to the formation of lung metastases (15).
Recent evidence indicates that the pre-metastatic sites are
shaped before tumor cell arrival to generate a tumor-hospitable
niche, which favors the metastatic cell seeding. The pre-
metastatic niche is conditioned by hematopoietic-derived cells,
such as myeloid cells and/or neutrophils (16, 17). These cells have
been detected in the pre-metastatic niche. Wculek and Malanchi
have recently reported that neutrophil-derived leukotrienes allow
for the colonization of lungs by cancer cells endowed with high
tumorigenic potential (17).
Neutrophils are primarily recruited by CXCR2 ligands (e.g.,
CXCL1, CXCL5, etc.). However, our studies have shown that
neutrophils can respond to other chemoattractant stimuli, such
as oxysterols (18), which in turn recruit them within the primary
tumors and contribute to tumor growth by exerting immune
suppressive and/or pro-angiogenic activities (18). Altogether,
these results highlight the role played by the cross-talk among
cancer cells, stroma and myeloid cells, including neutrophils, in
favoring primary and metastatic tumor cell seeding.
Here, we show that tumor-derived oxysterols, interfering
with molecular and cellular networks, modify primary and
metastatic tumor microenvironment (TME) and participate in
the formation of primary and metastatic growth of breast
tumors. We detected type-2 inflammation and neutrophil
increase in the TME of the 4T1 breast primary tumors.
These features were counteracted when we injected mice with
4T1 expressing SULT2B1b, which inactivates oxysterols. In
these mice, we detected a shift toward type-1 inflammation
concomitant with neutrophil reduction, DC increase and a
high CD8+IFNγ+/CD4+IL-4+ ratio. In the metastatic lungs, we
observed a reduction of neutrophils andmonocytes, as compared
to lungs from mock-4T1-bearing mice. Of note, a similar
difference was observed when we injected mice intraperitoneally
with conditioned medium from mock- or SULT2B1b-4T1.
RESULTS
Role of Oxysterols in Regulating Primary
Breast Tumor Growth
Our group has described how tumor-derived oxysterols
negatively condition tumor-infiltrating immune cells, thus
promoting tumor growth (13). To investigate whether and how
tumor-derived oxysterols were also able to regulate the metastatic
process, we selected a breast tumor model, i.e., the 4T1 cell line,
which spontaneously gives rise to lung metastases after an initial
growth when transplanted orthotopically in the mammary fat
pad of BALB/C mice. 4T1 cells express Cyp27a1 transcripts
(Figure 1A), which encode the enzyme responsible for the
generation of the oxysterol 27-Hydroxycholesterol (27-HC), and
Cyp27a1 protein (Figure 1B), as described in other breast cancer
models (15). To deplete 4T1 cells of active oxysterols we took
advantage of the oxysterol-inactivating enzyme sulfotransferase
2B1b (SULT2B1b), a strategy successfully used by our group
with other tumor models (18, 19). We therefore transduced
4T1 cell line with a lentivirus encoding the SULT2B1b (19),
which converts oxysterols in their sulfated, inactive forms,
thus blocking their capacity to bind the Liver X Receptors
(LXRs). As control, we transduced the 4T1 cell line with a mock
lentivirus (19). When injected orthotopically, both cell lines
formed palpable tumors starting from 7 days after injection
(Figures 1C,D). However, SULT2B1b-trasduced tumors showed
a significant growth delay both in terms of volumes and weights
(Figures 1E,F). This led to a statistically significant increase
of the overall survival of 4T1-SULT2B1b tumor-bearing mice
(Figure 1G). In vitro proliferation and Annexin V/PI assays
ruled out the possibility that the delayed tumor growth could
be the result of intrinsic defects induced by the activity of
SULT2B1b enzyme (Supplementary Figures 1A,B). Tumor
growth delay relied on the in vivo interaction between tumor
cells and an intact immune system, as demonstrated by tumor
challenge experiments in immune-compromised NOD-SCID
mice, showing similar rates of growth of SULT2B1b- and
Mock-4T1 tumors (Figure 1H).
Sulfotransferase 2B1b-Mediated Oxysterol
Depletion in 4T1 Tumor Cells Influences
the TME Composition
To evaluate whether previously identified cellular mechanisms
orchestrated by tumor-derived oxysterols (18, 19) were
responsible for the delay of SULT2B1b-4T1 growth in
vivo, we performed extensive flow cytometry analyses to
characterize and compare the tumor microenvironment
(TME) composition of SULT2B1b- and Mock-4T1 tumors. In
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FIGURE 1 | Analysis of the effects of SULT2B1b expression on the growth of 4T1 primary breast tumors. (A) In vitro qPCR analysis evaluating the expression of
cholesterol hydroxylase and StarD1 transcripts in 4T1 cells. StarD1 encodes a transport protein that regulates cholesterol transfer within the mitochondria.
(B) Expression of Cyp27a1 protein by 4T1 cells. The analysis was performed by immunohistochemistry using an anti-Cyp27a1 antibody. Original magnification 400x;
bar, 100µm. (C,D) H&E analysis of Mock-4T1 and SULT2B1b-4T1 tumors. At tumor-host interface it is visible a less dense inflammatory infiltrate in SULT2B1b-4T1
tumors. Original magnification 200x; bar, 100µm. (E) Mock-4T1 and SULT2B1b-4T1 tumor growth in BALB/C mice. Tumor cells were implanted orthotopically (n = 7
mice/group). (F) Tumor weight 14 days after tumor challenge. (G) Kaplan-Meier survival analysis of mice bearing Mock-4T1 and SULT2B1b-4T1 tumors (n = 10
mice/group). (H) Mock-4T1 and SULT2B1b-4T1 tumor growth in immunodeficient NOD-SCID mice (n = 4 mice/group). *P < 0.05; ****p < 0.0001 [Student’s t-test
and Log-rank (Mantel-Cox) test for survival experiments].
accordance with our previous work (18, 19), we observed
a reduction of Ly6G+ neutrophils in SULT2B1b-4T1
tumors by immunohistochemistry (Figures 2A,B). This
was confirmed more accurately by flow cytometry enumerating
the numbers of CD11b+Ly6G+neutrophils/mg of tumor tissue
(Figure 2C). Moreover, we detected increased numbers of
F4/80−CD11b+CD11c+ dendritic cells in SULT2B1b-4T1
tumors (Figure 2D). These cells are critically involved in tipping
the balance of the TME. In particular, low numbers of neutrophils
and high numbers of DCs have been shown to convert the
immune suppressive or pro-tumor TME toward a TME endowed
with an antitumor ability (20). We then analyzed the adaptive
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component of TME and we did not observe a significant
modification of CD3+, CD8+, or CD4+ T-cell numbers between
the two tumors (Supplementary Figures 2A–C). However, a
more in-depth analysis showed a difference in the ratio between
CD8+IFNγ+ T cells and CD4+IL4+ T cells (Figure 2E), with
an increase of type 1 T-cells in the SULT2B1b-4T1 TME. We
also observed an increased percentage of γδ T cells and a
decreased percentage of CD8+PD1+ T-cells in SULT2B1b-4T1
tumors (Figure 2F and Supplementary Figure 2D, respectively).
CD4+FoxP3+ Treg cells were equally represented in both
tumors (Supplementary Figure 2E). Furthermore, we did not
detect different numbers of monocytes (CD11b+Ly6C+ cells)
and macrophages (CD11b+F4/80+ cells) infiltrating the two
tumors (Figures 2G,H). To gain insights into the different
functional activity of these cells, we purified CD11b+ cells, also
including macrophages, from SULT2B1b- andMock-4T1 tumors
and analyzed by qPCR the prototypic genes discriminating
between type 1 and type 2 cells. However, we failed to observe
any significant diversity in terms of cell polarization between
SULT2B1b- and Mock-4T1 tumors (Supplementary Figure 3).
Overall, these results indicate that the depletion of active
oxysterols through the SULT2B1b enzyme deeply affects the
cellular components of the TME, tipping the balance toward
a TME made up of immune cells bearing phenotypic features
potentially responsible for antitumor responses. This was
confirmed by the analysis of cytokine transcripts present in
the growing tumors (Figure 3). We observed reduced levels of
transcripts encoding anti-inflammatory cytokines, such as Il10,
Il4, and Il13 in SULT2B1b-4T1 tumors. Additionally, we found
higher levels of Il2 and lower levels of m-csf, g-csf and mmp9
in SULT2B1b-4T1 tumors, the latter possibly correlating with
the lower number of neutrophils infiltrating SULT2B1b-4T1
tumors (Figures 3, 2C). In accordance with this hypothesis, we
detected decreased transcript levels of the neutrophil-secreted
proangiogenic factor Bv8 (Figure 3). Unexpectedly, we failed to
detect a difference in terms of Ifnγ transcripts.
Role of Oxysterols in 4T1 Metastasis
Formation
The decreased overall survival observed in Mock-4T1 tumor-
bearing mice (Figure 1D) led us to hypothesize a biological
role of oxysterols also in the metastatic process. Since the
orthotopic injection of 4T1 breast tumor cells gives rise to
lung metastatses (17), we analyzed and detected by histology
metastatic nodules in lungs of Mock-4T1- and SULT2B1b-
4T1-bearing mice (Figures 4A,B). To quantify the number
of metastases, lungs of tumor-bearing mice were processed
to obtain single cell suspensions, which were subsequently
cultured for 14 days in the presence of the 6-thioguanine to
select 4T1 metastatic resistant cells. We found an increased
number of metastatic colonies in Mock-4T1 as compared to
SULT2B1b-4T1 samples (Figure 4C). These data were confirmed
by immunohistochemical analysis (data not shown). Exploiting
the NGFr reporter gene encoded by both Mock and SULT2B1b
lentiviruses, we devised a complementary assay using qPCR to
measure the number of metastatic cells in the lungs (Figure 4D).
This assay confirmed that Mock-4T1 cells were more prone to
form lung metastases, as compared to SULT2B1b-4T1 cells. We
also detected an increased expression of NGFr transcripts in the
blood of Mock-4T1 tumor-bearing mice, though the results were
not statistically significant (data not shown). We hypothesized
that the decreased number of metastatic cells in the lungs could
be the result of the delayed growth of SULT2B1b-4T1 primary
tumors. Therefore, we modified the in vivo experimental design,
allowing the SULT2B1b-4T1 tumors to reach sizes equal to those
observed in 4T1-Mock tumors at the end-points. The analysis
of lungs demonstrated that the increased capacity of Mock-4T1
tumors to give rise a higher number of lung metastases was
independent of the primary tumor burden (Figures 4E,F).
The epithelial-mesenchymal transition (EMT) is a well-
established process allowing epithelial tumor cells to gain
migratory and invasive properties, ultimately leading to
metastasis formation (21). LXR activation in tumor cells has been
shown to induce the up-regulation of genes involved in the EMT
(15). Therefore, we sought to investigate whether a differentially
expression pattern of EMT genes was responsible for the different
metastatic behaviour of Mock- and SULT2B1b-4T1 cells.
However, epithelial (mCdh1) or mesenchymal (mSnai1, mSnai2
and mVIM) genes were not differentially expressed between
Mock- and SULT2B1b-4T1 cells (Supplementary Figure 4A).
Furthermore, the levels of TGFβ, a protein involved in EMT,
were not different in the supernatants of in vitro cultured Mock-
and SULT2B1b-4T1 cells (Supplementary Figure 4B), or when
measured in vivo (Supplementary Figure 4C). These results
suggest that the expression of SULT2B1b does not modify the
molecular pattern associated to EMT of 4T1 breast tumor cells.
Instead, we observed by flow cytometry a slight decrease of
β1 and β3 integrins in SULT2B1b-4T1 cells as compared to
Mock-4T1 cells, whereas α5 and αv integrins were similarly
expressed by the two cell lines (Supplementary Figure 4D).
Dissecting the Mechanisms Responsible
for the Different Metastatic Capabilities of
Mock-4T1 and SULT2B1b-4T1 Tumor Cells
To get insights into the mechanisms of metastasis formation we
performed in vivo metastasis formation assays. Unexpectedly,
when we injected tumor cells directly into the mouse tail vein,
SULT2B1b-4T1 cells colonized the lungs much more efficiently
as compared to Mock-4T1 cells (Figure 5A), indicating a more
pronounced attitude of SULT2B1b-4T1 cells to establish lung
nodules. To better understand how oxysterols affected the
metastatic process of 4T1 cells, we resorted to in vitro assays.
We thus performed standard migration and invasion assays,
where Mock- and SULT2B1b-4T1 cells were seeded on the
top chamber of transwell filters without or with Matrigel, and
were left to migrate to the NIH-3T3 conditioned media. No
differences were found between the two cell lines (Figures 5B,C).
However, when we performed the transendothelial migration
assays, in which tumor cells migrate to the NIH-3T3 conditioned
media by crossing a monolayer of HUVEC cells left growing
on top of the filter, the SULT2B1b-4T1 cells migrated much
more efficiently than Mock-4T1 cells (Figure 5D), mimicking
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FIGURE 2 | TME modifications in the presence of SULT2B1b-4T1 tumors. (A,B) Tumor-host interface of Mock-4T1 (A) and SULT2B1b-4T1 (B) primary breast tumors
immunostained with anti-Ly6G mAb. A reduced density of Ly6G+ neutrophils is visible in SULT2B1b-4T1 tumors (B). Original magnification 200x; bar, 100µm. (C,D)
Quantification of neutrophils (C) and dendritic cells (D) by flow cytometry analysis of Mock-4T1 and SULT2B1b-4T1 tumors after mechanical and enzymatic digestion.
Enumeration was expressed as the number of cells/mg of tumor tissue. (E) Ratio between CD8+ IFNγ+ and CD4+ IL4+ T cells. (F) Percentage of CD3+ γδ+ T cells.
(G,H) Quantification of the CD11b+Ly6C+ (G) and CD11b+F4/80+ (H) cells by flow cytometry analysis of Mock-4T1 and SULT2B1b-4T1 tumors after mechanical
and enzymatic digestion Enumeration was expressed as the number of cells/mg of tumor tissue. *p < 0.05. ***p < 0.001 (Student’s t-test).
the results obtained in vivo following the intravenous injection
of SULT2B1b-4T1 cells (Figure 5A). These results indicate that
4T1 tumor cells expressing SULT2B1b are endowed with a higher
capacity to give rise to metastases. Since this capacity is lost in
the presence of established primary tumors and does not depend
on the tumor size (Figures 4E,F), we hypothesized that the
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FIGURE 3 | qPCR analysis of cytokines, growth factors, MMP9 and Bv8 transcripts in Mock- and SULT2B1b-4T1 tumors. Tumors were collected 7 days after
orthotopic injection in BALB/C animals and subjected to RNA extraction and qPCR analysis. *p < 0.05; **p < 0.01 (Student’s t-test).
TME of SULT2B1b-4T1 tumors could influence the subsequent
metastatic cascade of 4T1 tumor cells.Mmp9 transcripts resulted
to be significantly decreased in SULT2B1b-4T1 tumors before
any difference in size could be observed (Figure 3). These results
correlated with the above-reported reduction of neutrophils in
the primary SULT2B1b-4T1 tumors (Figure 2C). Neutrophils
have recently been associated to the formation of lung metastases
in breast tumor models (17, 22). Both observations suggest
a possible contribution of the primary TME to the reduced
metastatic potential of SULT2B1b-4T1 tumors, independently
of intrinsic tumor cell modifications induced by SULT2B1b
expression and activity.
The above-reported results led us to hypothesize that the TME
of the primary tumors could be able to shape the environment
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FIGURE 4 | SULT2B1b expression affects in vivo metastatic behaviour of 4T1 tumor cells. (A,B) H&E analysis of Mock-4T1 and SULT2B1b-4T1 lung metastatic
nodules. The inflammatory component surrounding the SULT2B1b-4T1 lung metastatic nodule (B) is less dense than that surrounding the Mock-4T1 lung metastatic
nodule (A). Original magnification 200x; bar, 100µm. (C) Clonogenic assay and (D) qPCR analysis of lungs of tumor-bearing mice. (E) Primary tumor growth and (F)
qPCR analysis of lungs of tumor-bearing mice, in which Mock-4T1 and SULT2B1b-4T1 primary tumors were surgically removed after reaching the same size. **p <
0.01. (Student’s t-test).
of the lung metastatic niche. Immunohistochemistry with anti-
Ly6G mAb of lungs from tumor-bearing mice showed a
high neutrophil infiltration of metastatic lungs from Mock-
4T1- and SULT2B1b-4T1-bearing mice (Figures 6A,B). Similar
immunohistochemical features were also observed in the
lung interstitium from tumor-bearing mice (data not shown).
Immunohistochemical analyses were confirmed by FACS analysis
performed on the lungs of naïve and tumor-bearing mice. We
observed an increase of CD11b+Ly6G+ neutrophils in the lungs
of Mock-4T1 tumor-bearing mice as compared to both naïve and
SULT2B1b-4T1 tumor-bearing mice (Figure 6C). On the other
hand, CD3+ T cells were decreased in the lungs of Mock-4T1
tumor-bearing mice as compared to both naïve and SULT2B1b-
4T1 tumor-bearing mice (Figure 6D). An in-depth analysis
showed a slight difference of the percentage of CD3+CD4+
and CD3+CD8+ T cells in the lungs of Mock-4T1 and
SULT2B1b-4T1-tumor-bearing mice, with a lower percentage
and a higher percentage of tumor-infiltrating CD3+CD4+ and
CD3+CD8+ T cells, respectively, in the lungs of SULT2B1b-4T1-
bearing mice (Supplementary Figures 5A-C). The percentage
of CD4+IL4+ T cells and CD8+IFNγ+ T cells infiltrating
the lung metastases of Mock-4T1 and SULT2B1b-4T1-tumor-
bearing mice was extremely low and no difference between
the two groups was observed (Supplementary Figures 5D,E).
Differently from the primary tumors, we did not observe
any difference in the percentage of γδ T cells between the
two groups (Supplementary Figure 5F). Moreover, lungs of
SULT2B1b-4T1 tumor-bearing mice showed a decrease of
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FIGURE 5 | In vivo and in vitro analysis of SULT2B1b-4T1 cell metastatic capabilities. (A) qPCR analysis of lungs after the injection of SULT2B1b-4T1 cells in the tail
vein of naive mice. (B–D) in vitro migration assays using transwell chambers untreated (B), or coated with a matrigel layer (C), or filled up with a monolayer of HUVEC
cells left growing on top of the filter (D). ***p < 0.001; ****p < 0.0001 (Student’s t-test).
CD11b+Ly6C+ monocytes (Supplementary Figure 6A) and an
increase of CD11blowCD11c+ tissue resident macrophages
(Supplementary Figure 6B) (23), as compared to both naïve
(WT) mice and Mock-4T1 tumor-bearing mice. Finally,
CD11b+F4/80+ macrophages decreased in the lungs of Mock
and SULT2B1b tumor-bearing mice as compared to naive
(WT) mice (Supplementary Figure 6C). Similar results could
be obtained by treating naïve mice intraperitoneally with the
conditioned media (CM) of Mock- and SULT2B1b-4T1 cells.
Mice received 300 µl of CM intraperitoneally every day for
2 weeks. Lungs were then recovered and analyzed by flow
cytometry.We observed a different percentage of neutrophils and
macrophages in the lungs of naïve mice treated with SULT2B1b-
4T1 tumor CM (Figure 6E and Supplementary Figure 6F),
while other immune cells did not undergo any modifications
(Supplementary Figures 6D,E). Moreover, we did not detect any
significant difference of CD3+ T cells infiltrating lungs of Mock-
and SULT2B1b-4T1 bearing mice (Figure 6F).
Altogether these results suggest that in the 4T1 model
the enzymatic depletion of oxysterols in the primary tumors,
modulates the formation of lung metastases by regulating the
levels of immune cells infiltrating the metastatic TME. Indeed,
lung metastases of SULT2B1b-4T1 tumors were infiltrated by
lower numbers of tumor-promoting neutrophils and higher
numbers of CD3+ T cells, though the latter were not confirmed
by the intraperitoneal injections of CM ofMock- and SULT2B1b-
4T1 cells. To finally prove whether neutrophils, T cells or
both subsets were involved in lung metastasis formation, we
performed tumor challenge experiments in immunodeficient
NOD-SCIDmice, which lack lymphocytes. Although the primary
Mock- and SULT2B1b-4T1 primary tumors grew similarly in
immunodeficient NOD-SCID mice (Figure 1H), the number
of metastases in the lungs of SULT2B1b-4T1 tumor-bearing
mice was significantly lower as compared to lungs of Mock-
4T1 tumor-bearing mice (Figure 6G). These results strongly
suggest that neutrophils would represent the main drivers of lung
metastatic formation in the 4T1 breast tumor model.
Finally, to identify a possible correlation between increased
tumor-infiltrating neutrophils and oxysterol content in human
breast tumors, we interrogated 3661 primary breast tumor
samples, and we found a significant direct correlation between
the expression of transcripts identifying a neutrophil signature
and the expression of transcripts for CYP27A1, which encodes
the oxysterol 27-HC (r = 0.208; p< 0.0001) (Figure 6H).
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FIGURE 6 | SULT2B1b expression in the primary tumors affects the lung metastatic niche. (A,B) Immunoistochemical analysis of Mock-4T1 (A) and SULT2B1b-4T1
(B) lung metastases immunostained with anti-Ly6G mAb. The density of Ly6G+ neutrophils is reduced in SULT2B1b-4T1 tumors (B). Original magnification 200x; bar,
100µm. (C,D) Percentage of neutrophils (C) and CD3+ T-cells (D) by flow cytometry analysis of naïve lungs, Mock-4T1 and SULT2B1b-4T1 lung metastases after
mechanical and enzymatic digestion. *p < 0.05; ***p < 0.001 (ANOVA). (E,F) Percentage of neutrophils (E) and CD3+ T-cells (F) by flow cytometry analysis of lungs
collected from naïve mice treated with tumor conditioned media (TCM) from Mock-4T1 and SULT2B1b-4T1 tumors, after mechanical and enzymatic digestion. *p <
0.05; (Student’s t-test). (G) qPCR analysis for NGFR expression of lungs from Mock-4T1 and SULT2B1b-4T1 tumor-bearing NOD-SCID mice. **p < 0.01. (Student’s t
test). (H) Scatter plot (red dots) and linear regression (black line, slope 0.532) of expression values indicate a positive correlation between the expression level of
CYP27A1 and a neutrophil gene signature, in a compendium of 3661 primary human breast cancers (see Materials and Methods). The Pearson ρ quantifies the linear
dependence between the expression levels of CYP27A1 and of the neutrophil signature (p-value < 0.0001).
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DISCUSSION
Here, we have investigated the contribution of the LXR/oxysterol
axis to the formation of primary and metastatic breast tumors.
To this aim we took advantage of the sulfotransferases 2B1b
(SULT2B1b), which inactivates oxysterols through the sulfation
of hydroxyl groups (24). In line with our previous results
(19, 25), the injection of 4T1 breast tumor cells, genetically
engineered to express SULT2B1b, resulted in tumor growth
delay and prolonged overall survival (Figures 1E–G), indicating
that oxysterols contribute to the establishment of primary 4T1
breast tumors by impinging on antitumor immune responses,
as demonstrated by experiments carried out in immunodeficient
mice (Figure 1H). Neutrophils have been shown to play a dual
role within the TME, as they evolve from anti-tumour to pro-
tumour cells in mice bearing transplantable tumor cell lines (26).
Particularly, in the TME of 4T1 growing tumors, neutrophils
have been reported to have contrasting roles. Li et al. showed
that the depletion of CD11b+Gr1+ neutrophils decreased the
pro-tumorigenic effect of TGF-β, whereas Granot et al. reported
no effects in the growing tumors (27, 28). These different
outcomes could be dependent on the timing of neutrophil
depletion (26). We have shown that oxysterols released from
tumor cells recruit neutrophils endowed with pro-angiogenic
and immunosuppressive abilities through amechanism requiring
the CXCR2 chemokine receptor and independently of LXRs (18,
25). This mechanism could be also responsible for the different
number of neutrophils detected in Mock- and SULT2B1b-4T1
tumors, with a lower number of CD11b+Ly6G+ neutrophils
in tumors inactivating oxysterols by means of the SULT2B1b
enzymatic activity. Extensive flow cytometry analysis of the
TME of SULT2B1b-4T1 and Mock-4T1 tumors, highlighted
other cell differences characterizing these tumors. The ratio
between effector CD8+IFNγ+ and CD4+IL-4+ T cells, the latter
commonly endowed with a pro-tumor ability (29), was tipped
in favour of effector cells in the SULT2B1b-4T1 TME. This
observation is in accordance with the consolidated notion that
tumor growth control in immunocompetent mice is frequently
achieved through a T-cell response mediated by CD8+IFNγ+
effector T cells. These results are corroborated by tumor challenge
experiments in NOD-SCID mice, in which we failed to observe
the control of SULT2B1b-4T1 tumor growth. On the other
hand, these results indicate that tumor-derived oxysterols may
shape the TME inducing a pro-tumor milieu, as confirmed
by the detection in the TME of Mock-4T1 tumors of higher
levels of the type-2 cytokine transcripts Il4, Il13, as well as
the anti-inflammatory Il10 transcripts (30) (Figure 3). Of note,
the tumor-promoting T helper type 2 inflammation has been
reported in human breast tumor samples (31) and in human
pancreatic cancer, whereby it is associated to reduced overall
survival (32). Ifnγ transcripts were not affected by oxysterol
inactivation. However, we cannot rule out a distinct mechanism
of regulation of IFN-γ post-transcriptionally or at protein
level. Although these results are partly in accordance with
data reported in Figure 2E, additional levels of regulation may
affect the expression of cytokines and chemokines, including
post-transcriptional regulations. Therefore, these results deserve
further investigations at protein level to get conclusive results
conclude on the cytokines, chemokines and growth factors
released within 4T1-Mock and 4T1-SULT2B1b TMEs.
SULT2B1b-4T1 tumors also contained a higher number of
gamma delta (γδ) T-cells, an observation suggesting an antitumor
role played by these cells in our experimental setting. The role of
γδ T cells in the TME is greatly debated. γδ T cells were shown
to efficiently kill tumor cells by releasing perforins, granzymes
and IFNγ (33). Furthermore, the adoptive transfer of γδ T cells in
4T1 tumor-bearing mice has proven to be effective in contrasting
the tumor growth (34, 35). On the other hand, Coffelt et al.
have recently demonstrated that IL-17 released by γδ T cells
induces the expansion of neutrophils in mice bearing mammary
tumors, which in turn suppress the antitumor CD8+ T-cells
(36). Further investigations are therefore needed to define stimuli
and conditions associated to the TME and making γδ T cells
antitumor or protumor.
4T1 tumors metastasize spontaneously to the lungs when
injected orthotopically. This feature makes this model useful
to investigate the metastatic process. Since SULT2B1b-4T1
tumor bearing mice showed a lower number of lung metastases
(Figure 4), we asked how LXR/oxysterol axis influenced the
metastatic capacity of 4T1 tumors. Nelson et al. have shown that
LXR engagement increases the metastatic spreading of breast
tumor cells by activating the EMT pathway (15). However, the
intrinsic role of LXR/oxysterol axis to induce lungmetastases was
ruled out by the evidence that some transcripts characterizing
the EMT phenotype were similarly expressed by Mock- and
SULT2B1b-4T1 cells (Supplementary Figure 4A). Moreover, we
did not observe any difference in the levels of TGFβ, a key
mediator of EMT (21) between SULT2B1b-4T1 and Mock-
4T1 tumors, both in vitro and ex vivo. In contrast to the in
vivo experiments, SULT2B1b-4T1 tumor cells showed a higher
capability to form lungmetastases when injected i.v. (Figure 5A),
and to migrate across the endothelium when tested in vitro by
transendothelial migration assays (Figure 5D). We then asked
whether the cellular and molecular modifications induced by
tumor-derived oxysterols in the primary tumor sites were also
impacting on the metastatic cascade. Neutrophils, for example,
through the secretion of MMP9 and G-CSF, favour the metastatic
capacity of tumor cells (37, 38). In agreement with these results,
we found a higher percentage of neutrophils in the metastatic
lungs of Mock-4T1 mice, suggesting a possible role played
by oxysterols in recruiting immunosuppressive and pro-tumor
neutrophils in the metastatic lungs. This was further supported
by the experiments in NOD-SCID mice, where an increased
number ofmetastatic cells could be detected inMock-4T1 tumor-
bearing mice regardless of the absence of T cells. The role of
neutrophils in conditioning the metastatic niche is still debated
and might be dependent on the complex molecular and cellular
networks occurring in the TME (26). Indeed, some groups
have shown that neutrophils actively kill early metastatic cells
through the release of H2O2 (28). Other groups have instead
reported the pro-tumor role exerted by neutrophils in promoting
metastasis formation through the decrease of IFNγ production,
the secretion of the vasculature remodelling protein MMP9 and
the secretion of neutrophil-derived leukotrienes (17, 22). Factors
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released by the growing tumors are indeed able to induce such
an early recruitment of neutrophils in the lungs, as suggested by
our experiments with conditionedmedia fromMock-4T1 tumors
(Figure 6E).
Overall, these results demonstrate that oxysterols depletion
through the enzymatic activity of SULT2B1b reprograms the
tumor microenvironment favouring the control of breast tumors
and metastasis formation. Neutrophils are primarily involved
in this mechanism, though we cannot rule out a possible pro-
metastatic role exerted by CD11b+F4/80+ cells, which we found
decreased in the lungs of mice injected with conditioned media
of SULT2B1b-4T1 tumor cells. Finally, a work recently published
by Baek et al. (39) demonstrates that the oxysterol 27-HC
plays a pro-metastatic role in breast cancer models through the
recruitment of immune suppressive neutrophils in the metastatic
niche.
Our work opens new therapeutic avenues for the prevention
of the metastatic disease in breast cancer patients through
strategies counteracting oxysterol generation. This observation
is also supported by experiments reported in Figure 6H and
demonstrating a positive correlation between tumor-infiltrating
neutrophils and the expression of the CYP27A1 enzyme
generating the oxysterol 27-HC.
MATERIALS AND METHODS
Cell Lines and Reagents
4T1 mammary tumor cell line was cultured in RPMI 1640
(Roswell Park Memorial Institute) complemented with 10%
fetal bovine serum (FBS, Euroclone Ltd.), 2mM L-Glutammine
(GIBCO) and 1% penicillin/streptomycin (GIBCO). 4T1-
SULT2B1b and 4T1-Mock tumor cells were obtained by
engineering 4T1 cells with lentivirus encoding SULT2B1b or
empty vector encoding only the 1NGFr cell surface marker, as
described previously Villablanca et al. (19). Analysis of mRNA
and flow cytometry were performed when cells were in an
exponential growth phase. Reverse transcription was performed
by incubating 1–2 µg of total RNA [extracted using Trizol
reagent (Invitrogen) according to manufacturer’s protocol],
with MLV-Reverse Transcriptase (Promega) for 1 h at 42◦C.
Quantitative PCR was performed using real-time PCR (Viia7,
Applied Biosystems) using SyberGreen technology (see Table 1
for the list of qPCR primers). Cell staining was performed by
incubating the cells with specific and control antibodies at 4◦C for
20min. The following antibodies were used: anti-CD45 (30-F11),
-CD11b (M1/70), -CD11c (N418), -Ly6G (1A8), -Ly6C (HK1.4),
-F4/80 (BM8), -CD3 (145-2C11), -CD4 (GK1.5), -CD8 (53-6.7),
-PD1 (RPM1-30), -TCRγδ (GL3), -IFNγ (XMG1.2), and -IL-4
(11B11). These antibodies were all from Biolegend. Anti-FoxP3
(FJK-16s) was from eBiosceince. Anti-mouse/rat alpha5 (CD49e,
clone HMα5-1), anti-mouse alphaV Integrin (CD51, clone RMV-
7), anti-mouse/rat integrin beta3 (CD61 clone 2C9.G3) and
anti-mouse integrin beta1 (CD29 clone HMβ1-1) were from
Immunological Sciences and were a kind gift of Dr. Flavio
Curnis. Anti-Cyp27a1 rabbit antibody (Clone EPR7529) was
from Abcam.
TABLE 1 | List of qPCR primers.
Forward primer Reverse primer
Rpl13 TCAAGGTTGTTCGGCTGAAG GCCCCAGGTAAGCAAACTTT
Csf1 TCAACAGAGCAACCAAACCA ACCCAGTTAGTGCCCAGTGA
Csf2 CTGTCACGTTGAATGAAGAGGTAG AGCTGGCTGTCATGTTCAAGG
Csf3 GAGCAGTTGTGTGCCACCTA GCTTAGGCACTGTGTCTGCTG
Mmp9 CAATCCTTGCAATGTGGATG TAAGGAAGGGGCCCTGTAAT
Il10 CTGGACAACATACTGCTAACCG GGGCATCACTTCTACCAGGTAA
Il1β GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT
Il2 TGAGCAGGATGGAGAATTACAGG GTCCAAGTTCATCTTCTAGGCAC
Ifnγ ATGAACGCTACACACTGCATC CCATCCTTTTGCCAGTTCCTC
Il4 ACTTGAGAGAGATCATCGGCA AGCTCCATGAGAACACTAGAGTT
Il13 AGACCAGACTCCCCTGTGCA TGGGTCCTGTAGATGGCATTG
Cox-2 TGAGCAACTATTCCAAACCAGC GCACGTAGTCTTCGATCACTATC
Tnfα AGGGATGAGAAGTTCCCAAATG CACTTGGTGGTTTGCTACGAC
iNos GTTCTCAGCCCAACAATACAAGA GTGGACGGGTCGATGTCAC
Arg1 CCACAGTCTGGCAGTTGGAAG GGTTGTCAGGGGAGTGTTGATG
Mgl1 CAGAATCGCTTAGCCAATGTGG TCCCAGTCCGTGTCCGAAC
Fizz1 CCTGCTGGGATGACTGCTA TGGGTTCTCCACCTCTTCAT
Mrc1 AAGGCTATCCTGGTGGAAGAA AGGGAAGGGTCAGTCTGTGTT
NGFR ACAAGACCTCATAGCCAGCA CCCCTGTTCCACCTCTTGAA
Cdh1 CAGGTCTCCTCATGGCTTTGC CTTCCGAAAAGAAGGCTGTCC
Snai1 CACACGCTGCCTTGTGTCT GGTCAGCAAAAGCACGGTT
Snai2 TGGTCAAGAAACATTTCAACGCC GGTGAGGATCTCTGGTTTTGGTA
Vim CGTCCACACGCACCTACAG GGGGGATGAGGAATAGAGGCT
Cyp11a1 AACATCCAGGCCAACATTAC GGTCATGGAGGTCGTGTC
Cyp27a1 GACCTCCAGGTGCTGAAC CTCCTGTCTCATCACTTGCTC
Cyp46a1 GTGTGCTCCAAGATGTGTTTCT ACACAGTCTGAAGCGCGCGGT
Cyp7b1 TCAGGAAAGGCAAGATCTGCTGA CCTGTTGACTGCAGGAAACTGTCA
Lxrα AGGAGTGTCGACTTCGCAAA CTCTTCTTGCCGCTTCAGTTT
Lxrβ AAGCAGGTGCCAGGGTTCT TGCATTCTGTCTCGTGGTTGT
In vitro Proliferation and Apoptosis Assays
For the proliferation assay, 20.000 cells were plated in triplicate in
24-well plates and cultured at 37◦C. At the indicated time point
the cells were collected and counted by trypan blue exclusion. The
Annexin V-PI assay (apoptosis assay) was performed according
to the manufacturer’s instructions using the Annexin V-FITC
detection kit I (BD Biosciences). Cell pellets were resuspended
in 100 µl of binding buffer and incubated with 5 µl of FITC-
conjugated Annexin-V and 5 µl of PI for 15min at room
temperature in the dark. 400 µl of 1 × binding buffer was added
and the samples were immediately analyzed by flow cytometry.
Samples were run on a Canto II flow cytometer (BD) and
analyzed by FlowJo software, gating on live cells.
Tumor Challenge Experiments
For orthotopic experiments, cells were washed three times with
PBS without calcium and magnesium (PBS-). Cells were then
injected in the mammary fat pad of BALB/C mice or NOD-
SCID mice, and tumor volume was determined by measuring
three perpendicular axes with a caliper starting from day 7 after
injection. In some experiments, 30.000 Mock- or SULT2B1b-
4T1 cells were injected in the tail vein of BALB/C mice.
After 14 days, lungs were recovered and analyzed for NGFr
expression as reported above. Animal studies were approved by
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the Institutional Animal Care and Use Committee of the San
Raffaele Scientific Institute (IACUC n◦ 656). All the experiments
in vivo were performed by using BALB/C mice, with exception
of the experiments reported in Figures 1H, 6G, whereby we used
NOD-SCID mice.
Immunohistochemistry
Heat-induced antigen retrieval in Tris-EDTA buffer (pH 9.0)
for 30min at 97 ◦C was used, followed by blocking of
endogenous peroxidase with 3% H2O2 and incubation with
3% of normal bovine serum. Ly6G (1A8 clone; BioLegend)
primary antibody was incubated for 1 h at RT, followed by
detection with rat on mouse HRP conjugated-polymer (RT 517,
Biocare Thermo Scientific, Fremont, CA, USA) and developed
with DAB chromogen. Tissue sections were counterstained with
hematoxylin and evaluated with a Nikon i80 microscope.
Analysis of Tumor-Infiltrating Immune Cells
Tumors were recovered and weighted at day 14 of growth,
then digested using a mix of Collagenase A, B and D (final
concentration 1,7 mg/ml; Roche) for 30min at 37◦C. Digested
samples were passed through a 70µm cell strainer, washed
and counted. Cells were then stained were stained with
Live/Dead Staining (Life Technologies), then with a mix of
antibodies (Biolegend) according to manufacturer’s instructions
and analyzed by flow cytometry. For gating strategy see
Supplementary Figures 7, 8. For intracellular staining, cells were
incubated in RPMI 10% FBS with PMA 100 ng/ml, ionomycin
500 ng/ml and brefeldin 10µg/ml (Sigma-Aldricht) for 3 h al
37◦C. Then, cells were stained with Live/Dead Staining (Life
Technologies) and specific or control antibodies. Cells were
finally permeabilized using Perm/wash kit (BD Biosciences)
and stained with relevant intracellular antibodies. Intracellular
FoxP3 staining was performed using Foxp3/Transcription Factor
Staining Buffer Set (eBioscience). mRNA analysis was performed
on homogenized tumors using TRIZOL reagent (Invitrogen),
as reported before. In some experiments, mRNA analysis was
performed on CD11b purified cells. Purification was carried
out with anti-PE microbeads and Miltenyi kit according to
manufacturer’s instructions. CD11b isolation purity was >95%
and total RNA was isolated through RNeasy Qiagen Kit, then
reverse transcription was performed as reported above.
qPCR Analysis of Transcripts Encoding
Cytokines, Growth Factors and
Pro-Angiogenic Factors in Mock- and
SULT2B1b-4T1 Primary Breast Tumors
Tumors were recovered after 7 days (before any significant
difference in weight could be observed) and total RNA
was extracted using Trizol reagent (Invitrogen) according to
manufacturer’s protocol. Reverse transcription and quantitative
PCR analysis was performed as reported above.
Analysis of Lung Metastasis
In the clonogenic assay, 7.000 Mock- or SULT2B1b-4T1 cells
were orthotopically injected in the mammary fat pad of BALB/C
mice (40). Lungs were recovered after 28 days of tumor growth
and washed twice in PBS, then digested by the collagenase mix
for 75min at 4◦C on a rotating wheel. Cell suspension was
passed through a 70µm cell strainer and washed once with RPMI
10% FBS. Cells were then seeded in 6-well plates at increasing
serial dilutions in the presence of 60µM 6-thyoguanine (Sigma-
Aldrich). After 2 weeks of culture, the colonies were manually
counted at the lowest dilution.
A complementary assay was designed to quantify the
metastatic cells in the lungs and blood, using qPCR. Primers were
designed on the coding sequence of NGFr reporter gene. Lungs
were directly homogenized by Trizol and mRNA was extracted
and analyzed as reported above. Blood samples were incubated
in RBC lysis Buffer (Biologend) according to manufacturer’s
instructions, then lysed by Trizol and processed as reported
above.
Migration/Invasion/Transendothelial
Migration Assays
For the migration assay, Mock- or SULT2B1b-4T1 cells were
starved overnight, then cells were detached and counted. 30.000
cells were seeded in the top chamber of 8µm transwell insert
(Millipore) in RPMI complemented with 0.5% BSA and left
to migrate toward NIH-3T3 conditioned media for 8 h. Cells
in the upper part of the filters were removed with a cotton
swab, then the filters were fixed in 70% ethanol for 10min. A
cotton swab was used again to remove ethanol in excess and the
filters were left to air dry for 15min. Filters were then stained
with crystal violet (Sigma-Aldrich) for 10min, then carefully
washed in distilled water. Migrated cells were then counted using
a light microscope. For the invasion assay, a 100 µl layer of
Matrigel Growth Factor Reduced Basement Membrane Matrix,
Phenol Red-Free (Corning; 0.9 mg/ml) was placed in the top
chamber and left for 1 h at 37◦C before seeding the cells. For
the transendothelial assay, 45.000 HUVEC cells were seeded in
the top chamber of transwells and cultured overnight to obtain a
confluent monolayer barrier. The day after, Mock- or SULT2B1b-
4T1 cells were seeded and left to migrate for 16 h, and then
processed as reported above.
Lung Histological Analysis
Lungs from tumor bearing mice were recovered, washed twice
in PBS and fixed in formalin. Processing of the samples was
performed by the Institutional Mouse Histopathology Facility.
Analysis of Lung-Infiltrating Immune Cells
Whole lungs were recovered in order to obtain an unbiased
analysis of the entire organ. Lungs from tumor-bearingmice were
recovered, washed twice in PBS and digested by the collagenase
mix for 75min at 4◦C on a rotating wheel. Cell suspension was
passed through a 70µm cell strainer, washed once with PBS
and counted. Cells were then stained with a mix of specific
and control antibodies (Biolegend) according to manufacturer’s
instructions and analyzed by flow cytometry. For gating strategy
see Supplementary Figure 9.
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Tumor Cells Conditioned Media
Preparation and Administration
Mock- or SULT2B1b-4T1 cells were cultured in IMDM without
FCS and phenol red (GIBCO) for 24 h. Supernatants were then
collected and centrifuged to remove cell debris, aliquoted and
stored at −80◦C until use. Mice received 300 µl of conditioned
media intraperitoneally every day for 2 weeks, then lungs were
recovered and analyzed by flow cytometry as reported above.
Collection and Processing of Breast
Cancer Gene Expression Data
We started from 4640 breast cancer samples obtained from 27
major data sets comprising microarray data normalized and
annotated with clinical information as described in Enzo et al.
(41). This resulted in a breast cancer compendium comprising
3661 unique samples from 25 independent cohorts (41). The
neutrophil signature is composed of the genes CXCR2, ITGAM,
MPO, and FUT4 and its average expression has been calculated as
the average expression of all signature genes in all the samples of
the breast cancer compendium. All analyses have been conducted
in R (version 3.3.2).
Data Analysis
Unless otherwise indicated, all experiments were repeated
at least 3 times. Data were analyzed by one-way ANOVA
followed by Tukey’s multiple comparison test or Stu-
dent’s t-test using GraphPad Prism software. Data
were expressed as mean ± SD, while other results
were shown as mean ± SEM. P values are presented
in figures as P < 0.05; P < 0.01; P < 0.001; or P <
0.0001.
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